Jubilant Radiopharma
Steven Horvath is an accomplished professional in the pharmaceutical industry with extensive experience in quality assurance and project management roles. As a Senior Project Manager in R&D at Jubilant DraxImage since January 2021, Steven leads critical projects. Previously, as Associate Director of Quality Assurance at Knight Therapeutics Inc., Steven developed internal processes, managed GMP compliance, and coordinated product release activities. Steven held various managerial positions at Paladin Labs, overseeing validation programs and technology transfers. Early career experience includes analytical roles at KABS Laboratories Inc. and teaching assistance at the University of Ottawa. Steven holds a Master’s degree in Chemistry from the University of Ottawa and a Bachelor’s degree in Chemistry from Concordia University.
This person is not in any offices
Jubilant Radiopharma
Jubilant Radiopharma is an industry leading pharmaceutical company specializing in nuclear medicine focused on developing, manufacturing, commercializing and distributing high quality and sustainable diagnostic and therapeutic agents for the sole purpose of Improving Lives Through Nuclear Medicine on a global scale.